Cameron Hurst Procter & Gamble PG-N DON'T BUY May 08, 2019

Very stable, reliable earnings. Decent, but not fantastic, growth. About 7% earnings growth forecast for next little while, but you're paying 23-24x PE. 

OK if you think a recession is around the corner. He doesn't, so he'd favour COST and WMT for continued mid-cycle economic growth. 

They report Friday. Last quarter, their China numbers were terrible and he doubts they can turn it around so quickly. He sold it this week.

Trades at 24x forward PE at only 1% organic growth. She's surprised they raised prices again, though they have pricing power, but at some point it will hurt volumes.

Eventually as they keep raising prices (since Covid), volumes will do gown. He wrote a $175 call against this, expiring in 7 days.

They beat on the topline, but missed the bottom, because China was -15%, though it was expected. Organic sales were fine and reiterated guidance. Trades at a too-pricey 24x forward. He doesn't like staples, but continues to like this.

A dividend play for 2025 at 2.38%. Not sexy, but consistently generates earnings, free cash flow, and each year grows its dividend. Offers growth wealth generation over time.

It reports Wednesday. He fears they might struggle with the strong USD in China

Is enjoying the rotation out of semis/tech stocks today, up 3.38%. It's been undervalued lately. Has more room to run; he expects the rotation to continue beyond today.

It has one of the greatest consumer product lines in the world. A dividend aristocrat that has raised its dividend for 70 years. It yields only a 2.68% dividend yield, falling short of current interest rates and bond yields.

Have suffered from a strong dollar when they return their overseas profits back home, but going forward will benefit from a weaker USD.